Pnc Financial Services Group, Inc. Ginkgo Bioworks Holdings, Inc. Transaction History

Pnc Financial Services Group, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$0.28 - $1.16 $4,444 - $18,413	-15,874 Reduced 41.89%	22,018 $7,000
Q1 2024 May 10, 2024	BUY	$1.06 - $1.67 $1,335 - $2,104	1,260 Added 3.44%	37,892 $43,000
Q4 2023 Feb 09, 2024	BUY	$1.26 - $1.79 $5,712 - $8,115	4,534 Added 14.13%	36,632 $61,000
Q3 2023 Nov 13, 2023	BUY	$1.61 - $2.54 $11,331 - $17,876	7,038 Added 28.08%	32,098 $58,000
Q2 2023 Aug 11, 2023	BUY	$1.14 - $1.95 $2,213 - $3,786	1,942 Added 8.4%	25,060 $46,000
Q1 2023 May 15, 2023	SELL	$1.2 - $2.19 $19,213 - $35,064	-16,011 Reduced 40.92%	23,118 $30,000
Q4 2022 Feb 10, 2023	SELL	$1.63 - $3.52 $9,920 - $21,422	-6,086 Reduced 13.46%	39,129 $66,000
Q3 2022 Nov 10, 2022	BUY	$0.73 - $3.74 $16,130 - $82,642	22,097 Added 95.58%	45,215 $141,000
Q2 2022 Aug 12, 2022	BUY	$2.2 - $4.2 $24,948 - $47,628	11,340 Added 96.28%	23,118 $55,000
Q1 2022 May 12, 2022	BUY	$2.83 - $8.69 $22,011 - $67,590	7,778 Added 194.45%	11,778 $47,000
Q4 2021 Feb 11, 2022	BUY	$8.31 - $14.92 $33,240 - $59,680	4,000 New	4,000 $33,000

48.1M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $12.1B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.